


Exploring the people, challenges, and opportunities impacting the global #medtech regulatory, reimbursement and policy communities. Likes,RTs,etc ≠ endorsement.


FDA novel device authorizations hit a five-year high of 121 in FY 2026. With FDA novel device authorizations reaching a five-year high in FY 2026, what do you think this growth signals for the future of #medtech innovation?

2028 will reshape orthopedic #device markets as mandatory CJR-X bundled payments accelerate the shift to ASCs. BTIG's Ryan Zimmerman explains the impact. Watch here: bit.ly/4zww0zz

2027 could reshape #MedTech policy. With Bernie Sanders set to lead the Senate HELP Committee, FDA user fees and MDUFA VI face a pivotal year. Read more: bit.ly/4AwkXY2

The #medtech landscape never stops evolving. Stay informed on FDA regulations, #reimbursement, and market access with Market Pathways: bit.ly/48NIW96

Want more? Get access to the #medtech industry's only comprehensive database for regulatory, policy, and guidance docs and more: bit.ly/4zEl6Zu


200+ PCCPs are on FDA's books as US and UK regulators explore greater flexibility for adaptive AI #medicaldevices. Discover what this means for future device modifications: bit.ly/4j6EVCO

3 change categories shape how medical device manufacturers navigate EU #MDR requirements. Learn more about Scarlet's SaMD framework and what upcoming guidance could mean for innovation: bit.ly/3UKRdY5

November 2026 brings new #FDA device approvals, 2 Breakthrough Device Designations, Class I recalls, and regulatory updates shaping #medtech. Explore the latest: bit.ly/4er2LXe

The final day of #InnovationSanDiego 2026 begins with a closer look at the evolving #medtech landscape. Up next is “Spotlight: Market Pathways,” featuring @Filmoreorless, Executive Editor of @Market_Pathways.

#ICYMI: One overlooked difference between FDA QMSR and EU MDR could complicate your risk management strategy. The #FDA and EU MDR have different expectations for medical device risk management. See how they compare: bit.ly/4jvzfD9

The next chapter of #medtech is already taking shape. Explore what a new administration could mean for the industry with a FREE Market Pathways feature article: bit.ly/4hR1ZoA

The right #marketaccess strategy can make all the difference in bringing medical technologies to market. We have the tools to make it easier than ever before. Get them all here: bit.ly/4hV6FtA

3 areas shaping #medtech: regulation, reimbursement, and market access. Stay informed with expert insights from the Market Pathways newsletter: bit.ly/4dMJuiL

3 reasons to listen to the Market Pathways Podcast: • Stay ahead of #medtech policy • Hear from industry experts • Gain real-world insights Listen now: bit.ly/4A3yPcf